Heads or Tails ! 💰💰
Scenario#1 or Scenario#2 ! 💰💰
#crams #cro #cdmo

Across Animal, Agro / Crop and Human Pharma, Biotech
#CRAMS is like an ‘auto ancillary’ partnering with OEMs (life sciences innovators) and helping customer’s science and intellectual property via their cross-customer learnings and scale.

Extending this thread to spell out few key differentiators for high quality #CDMO #CMO #CSM
1.Partnership mindset – best lab-to-market innovations are those that are developed via global partnerships where innovator and supplier teams collaborate. Innovator gets the necessary knowledge and commercial-scale production from #CDMO #CSM #CMO #CRAMS #CRO
Sticky Relationship: When products / services are highly differentiated – suppliers (#cdmo #cro #crams) will be more powerful! If it is expensive/disruptive to move from one supplier to another, buyer (innovator) becomes relatively weak and dependent! #customsynthesis
Great respect for innovators’ intellectual property: #CDMO #CRAMS #CRO must have unquestionable intellectual property & data integrity track record. For innovators – data confidentiality, data integrity and protection of their IP is way more important than simple cost arbitrage.
Courage to sacrifice short-term gains for long-term glory: One way to throw competitors off balance is to mask high performance so rivals fail to see your success until it’s too late!

#CRAMS firm must have the strategic intent to invest in requisite technology & infrastructure.
State-of-the-art-infrastructure & technology platforms - health care industry has also shifted toward personalized medicine, with more pharma #CRAMS producing smaller volumes of medications that target very small patient populations, such as people with specific genetic traits.
Impeccable regulatory compliance: Locking-in customers and locking-out competitors having iffy cGMP / FDA track record.

In last few years USFDA censure / fines / import bans have separated the men from the boys in #CDMO #CRAMS #CRO

#Hikal AR adds more:
Investments in Capacity: #CDMO is CAPEX upfront! Often 5 years ahead of any material cash flow (#Biocon Malaysia facility being one such example). Filings, Validations and Regulatory approvals take time!

#API / #CRAMS report depreciation / pain upfront | Gains are back ended!
Relationship Profile: Your #CRAMS quality is determined by the profile of customers you serve!

Take #syngene for instance – global giants like #Amgen, #GSK, Bristol-Myers Squibb, #Baxter and many more have not hesitated to partner with them to expedite their research pipeline.
Lastly, don’t bet your house (25-30% portfolio) on just one or two #CRAMS / #CSM stocks as these businesses have long gestation periods and lumpy cash flows.

However – the longevity of runway and sustainability is unquestionable so avoiding them is also not a prudent strategy!

• • •

Missing some Tweet in this thread? You can try to force a refresh

Keep Current with Self-awareness | 0 Cloning | Conviction | Patience

Self-awareness | 0 Cloning | Conviction | Patience Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!


Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!


0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy


3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!